ArticleFrontiers in cardiovascular medicine2026
Efficacy and safety of FangJiHuangQi granule in patients with heart failure: a protocol of randomized, placebo-controlled trial.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: FangJiHuangQi Granules (FJHQG) is a Chinese patent medicine that alleviates heart failure (HF) symptoms derived from the formula FangJiHuangQi decoction. Previous experiment has revealed that FangJiHuangQi decoction alleviated pathological injury in rats with HF. This trial intends to evaluate FJHQG's efficacy and safety as a complementary therapy in addition to conventional drug treatment. Methods: This trial is a randomized, double-blind, placebo-controlled study that recruits 100 patients with HF. Participants will be randomly assigned into the intervention and control groups ( Discussion: This study will evaluate the efficacy and safety of FJHQG in HF treatment and to examine potential mechanisms, offering new insights into HF treatment. Clinical Trial Registration: ChiCTR.org, ChiCTR2400080029.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.